Braveheart Bio, Inc. - Common Stock (NQ:BRVE)Price and VolumeDetailed Quote
Top NewsMore News
Braveheart Bio to Participate in Stifel Cardiometabolic Forum
September 16, 2026
Performance
52-Week Range
38.1% below 52-week high
19.81
17.8652W Low
32.0052W High
1 Week
10.0% below 1-week high
17.861W Low
22.021W High
Braveheart Bio, Inc. - Common Stock (BRVE) traded between $17.86 and $32.00 over the past 52 weeks and last traded at $19.81, 38.1% below its 52-week high. Over the past week it ranged between $17.86 and $22.02.
Past 12 Months
1W
-$1.54
1M
-$6.83
3M
-$9.99
6M
-$9.99
YTD
-$9.99
1Y
-$9.99
BRVE was -33.5% over the past year, -33.5% over six months, -33.5% year to date, -7.2% in the last week.
12 Months vs Market
BRVE
DIA
SPY
QQQ
IWM
Over the past 12 months BRVE returned -33.5% versus DIA (Dow) +12.6%, SPY (S&P 500) +17.3%, QQQ (Nasdaq 100) +23.9% and IWM (Russell 2000) +13.8%.
Volume & Liquidity
0.04× 3-mo avg
Today 19,739
3-mo avg 551.8K
1W
1M
3M
6M
YTD
1Y
BRVE most recently traded 19,739 shares against a 3-month average daily volume of 551.8K. More NewsRead More
Braveheart Bio to Participate in Cantor Global Healthcare Conference
September 01, 2026
Insiders Are Betting Big on These 3 Healthcare Stocks ↗
August 31, 2026
Frequently Asked QuestionsIs Braveheart Bio, Inc. - Common Stock publicly traded?
Yes, Braveheart Bio, Inc. - Common Stock is publicly traded.
What exchange does Braveheart Bio, Inc. - Common Stock trade on?
Braveheart Bio, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Braveheart Bio, Inc. - Common Stock?
The ticker symbol for Braveheart Bio, Inc. - Common Stock is BRVE on the Nasdaq Stock Market
What is the current price of Braveheart Bio, Inc. - Common Stock?
The current price of Braveheart Bio, Inc. - Common Stock is 19.81
When was Braveheart Bio, Inc. - Common Stock last traded?
The last trade of Braveheart Bio, Inc. - Common Stock was at 10/12/26 10:31 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|